Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

Author(s):
Tabrizi, S.J.; Reilmann, R.; Roos, R.A.C. (0000-0001-5591-1133); Durr, A.; Leavitt, B.; Owen, G.; Jones, R.; Johnson, H.; Craufurd, D.; Hicks, S.L.; Kennard, C.; Landwehrmeyer, B.; Stout, J.C.; Borowsky, B.; Scahill, R.I.; Frost, C.; Langbehn, D.R.; TRACK-HD Investigators
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-01-31
Language
English
Is part of
The Lancet Neurology (2012), Vol. 11, no. 1, p. 42-53
hdl
1887/118261
doi
10.1016/S1474-4422(11)70263-0